A new market study reveals a significant growth trajectory for the global personalized medicine and cell therapy market. Valued at USD 7.92 billion in 2024, the market is projected to reach USD 21.72 billion by 2032, expanding at a robust Compound Annual Growth Rate (CAGR) of 13.44% during the forecast period. This remarkable growth is fueled by a paradigm shift in healthcare from a o... https://www.databridgemarketresearch.com/